This policy explains how AI-assisted functionality may be used in the MediAxis Platform and how customers must review, control, and use AI-assisted inputs and outputs.
AI-assisted outputs must be verified against source records before use.
Output review →MediAxis is never the sole basis for legal, medical, or insurance decisions.
High-impact decisions →AI processing of PHI must occur under a completed Business Associate Agreement.
HIPAA terms →This AI Usage Policy / AI Terms explains how AI-assisted functionality may be used in MediAxis and how customers and users must review, control, and use AI-assisted inputs, outputs, and workflow materials.
These AI Terms apply to customers, administrators, authorized users, trial users, and any person using AI-assisted MediAxis features through an approved customer account. They supplement the Terms and Conditions, Privacy Policy, Customer SaaS Agreement, Data Processing Agreement, Business Associate Agreement, Subprocessor Disclosure, and applicable order or product documentation.
If a signed agreement, BAA, DPA, or order gives a customer more specific AI, privacy, security, retention, or regulated-data terms, that signed document controls for that customer to the extent it conflicts with this policy.
MediAxis AI Functionality is intended for business and professional workflows involving medical records, medical-legal matters, claims, insurance, medical-provider review, Qualified Medical Evaluator, Agreed Medical Evaluator, Independent Medical Examiner, disability claims, life-insurance applications, mass tort matters, workers' compensation, personal injury, medical malpractice, medical-product matters, and related professional use cases.
MediAxis is not intended for consumer self-diagnosis, emergency medical use, direct patient care, self-representation legal advice, autonomous claim adjudication, underwriting decisions, treatment recommendations, or other unsupported consumer or high-impact uses.
MediAxis AI Functionality may assist with record intake, text extraction, classification, document grouping, chronology support, medical-record indexing, summarization, retrieval, source-reference support, issue spotting, issue organization, reasoning assistance, review support, draft-output generation, and workflow quality checks.
MediAxis may help identify treatment events, provider information, medication history, medical bills, claim references, relevant dates, missing or duplicate records, inconsistent information, source citations, and possible strengths, weaknesses, damages, causation points, or other case-review observations. These outputs are decision-support materials and require customer review.
The AI features available to a customer depend on the applicable order, plan, configuration, user permissions, product documentation, and signed agreement. LezDo TechMed Pvt Ltd may add, modify, limit, suspend, or retire AI features for product, legal, security, operational, compliance, or provider-dependency reasons.
Feature descriptions do not promise that every AI feature will be available to every customer, matter, document type, jurisdiction, use case, account, or plan.
MediAxis AI Functionality does not provide legal advice, medical advice, expert opinions, testimony, diagnosis, treatment recommendations, claim determinations, insurance coverage decisions, underwriting decisions, settlement recommendations, disability determinations, benefit determinations, or regulatory decisions.
Use of AI Functionality does not create an attorney-client, doctor-patient, fiduciary, expert-witness, insurer-insured, claims-adjuster, broker-client, or professional advisory relationship between LezDo TechMed Pvt Ltd and any customer, user, patient, claimant, insured person, applicant, provider, expert, attorney, law firm, or third party.
Customers must not submit Inputs subject to undisclosed court restrictions, protective orders, patient restrictions, professional confidentiality limits, special statutory restrictions, employment restrictions, substance-use treatment restrictions, genetic information restrictions, insurer restrictions, product-safety confidentiality limits, or third-party contractual restrictions unless the customer has authority and required written terms are in place.
Customers are responsible for identifying and enforcing any client, patient, claimant, insured-person, policy-applicant, court, insurer, regulator, protective-order, engagement-letter, or matter-specific restriction on AI use before submitting records to MediAxis AI workflows. If a matter must not use AI-assisted processing, the customer must route that matter outside AI-enabled workflows or disable the relevant functionality where available.
Government identifiers, Social Security numbers, insurance identifiers, policy numbers, claim numbers, biometric information, genetic information, minors' information, and similar sensitive identifiers may be submitted only where necessary for an authorized matter workflow, legally permitted, and supported by the required customer authority and contractual terms.
If users submit recordings, transcripts, deposition audio or video, interview materials, call notes, communication records, or similar materials, the customer is responsible for required notices, consents, recording-law compliance, privilege review, confidentiality handling, participant permissions, and any restrictions on transcription, summarization, disclosure, or reuse.
AI-assisted results depend on the completeness, accuracy, legibility, OCR quality, language, format, metadata, and context of the Inputs. Customers and users are responsible for checking whether uploaded records are complete, current, assigned to the correct matter, and appropriate for the requested workflow.
Users should avoid unnecessary sensitive information in prompts and should structure prompts, instructions, and matter context accurately. Users must not deliberately submit false, misleading, malicious, unauthorized, or irrelevant Inputs to manipulate outputs or obscure source-record issues.
Customers must train authorized users on approved AI workflows, sensitive-record handling, prompt discipline, source-record verification, client or matter restrictions, prohibited external AI use, and escalation of suspected AI errors. Training should be practical enough that users know what records may be submitted, what must be reviewed, and when to stop and ask for approval.
AI-assisted Outputs may be incomplete, inaccurate, inconsistent, outdated, biased, unsupported by the full record, affected by OCR or source-file quality, or unsuitable for a particular legal, medical, insurance, claims, expert-review, disability, life-insurance, product-safety, or evidentiary purpose.
MediAxis must not be used as the sole basis for legal, medical, insurance, underwriting, disability, life-insurance, benefits, court, expert, employment, or similar high-impact decisions. Customers remain responsible for final human review and final decisions.
Users must not represent AI-assisted Outputs as independently verified legal, medical, insurance, expert, evidentiary, or regulatory conclusions unless an authorized professional has completed the required review.
Users must not misrepresent MediAxis Outputs as independently human-created, court-ready, medically verified, expert-approved, insurer-approved, regulator-approved, or professionally reviewed unless the required professional review and approval have actually occurred.
Where law, court rule, professional rule, customer policy, client instruction, regulator expectation, insurer rule, or evidentiary practice requires disclosure of AI assistance, the customer is responsible for making that disclosure and deciding whether the Output may be used.
Customers are also responsible for deciding whether AI use should be disclosed to clients, patients, claimants, insured persons, applicants, courts, regulators, insurers, experts, opposing parties, or other stakeholders when AI materially contributes to a work product, affects professional advice, influences fees, or is otherwise subject to disclosure obligations.
Attorney, law-firm, provider, expert, insurance, and claims customers remain responsible for their own professional duties, including competence, confidentiality, supervision, client or patient communication, privilege protection, fee reasonableness, court rules, insurer rules, regulator expectations, and matter-specific instructions.
MediAxis is not an underwriting, adverse-action, benefit-denial, claim-denial, eligibility, or automated decision system unless a signed agreement expressly states otherwise. Insurance, disability, life-insurance, and claims customers remain responsible for their own laws, governance programs, explainability obligations, notices, appeal rights, and human decision-making requirements.
Users must not remove, alter, fabricate, obscure, or misrepresent source references, citations, provenance indicators, review status, document context, or limitations associated with an Output. Customers should preserve source records and review notes needed to support their professional use of Outputs.
Users must not use MediAxis AI Functionality for unlawful, deceptive, abusive, harmful, infringing, privacy-invasive, unauthorized, or security-risking purposes. Users must follow the Acceptable Use Policy and applicable customer agreements.
Users must not use AI Functionality to generate false evidence, fabricate medical facts, falsify claim information, misrepresent case strength, hide missing records, impersonate a professional, mislead a court or insurer, create unauthorized legal or medical advice, or evade legal, medical, insurance, evidentiary, or professional obligations.
Users must not upload Customer Data, Inputs, Outputs, prompts, source excerpts, medical records, claim files, legal records, insurance records, or MediAxis workspace materials to external AI tools or unapproved systems unless the customer has approved that tool and applicable privacy, security, BAA, DPA, confidentiality, and professional-responsibility requirements are satisfied.
Customers must maintain a practical approved-tool process for AI use involving MediAxis data. That process should identify which tools may be used, what categories of data may be used with each tool, who may approve exceptions, and how the customer will prevent staff from moving confidential, privileged, PHI, claim, insurance, or legal records into consumer or unvetted AI systems.
Users must not use MediAxis, Inputs, Outputs, source excerpts, prompts, or workflow materials to train, benchmark, validate, reverse engineer, or improve a competing system, external model, or unrelated product without express written authorization from LezDo TechMed Pvt Ltd and the customer.
Customers should periodically review user access, AI-enabled workflows, matter restrictions, external AI exceptions, output quality, error reports, and compliance with their own professional duties. The review should be frequent enough to match the sensitivity and volume of the customer's MediAxis use.
Users must not attempt prompt injection, data exfiltration, model abuse, automated scraping, credential sharing, bypassing access controls, removing safety controls, submitting malware, extracting another customer's data, probing system instructions, or using AI Functionality to compromise MediAxis or any third-party system.
LezDo TechMed Pvt Ltd may use operational, diagnostic, aggregated, de-identified, or non-customer-identifying information to maintain, secure, troubleshoot, and improve MediAxis. LezDo TechMed Pvt Ltd does not re-identify de-identified Customer Data except where permitted for security testing, validation of de-identification controls, legal compliance, or as otherwise allowed by the governing agreement and applicable law, and does not use that information for advertising or unrelated data products.
AI-related Inputs, Outputs, prompts, source excerpts, logs, embeddings, temporary files, extracted text, and workflow context are retained and deleted according to the applicable Privacy Policy, Data Retention Policy, Data Deletion / Account Termination Policy, BAA, DPA, order, and signed customer agreement. If no different period is stated, the general Customer Data lifecycle includes retention during the subscription, a thirty-day post-termination export window where available, active production deletion generally within thirty days after the export window or verified deletion request, and ordinary backup aging generally within approximately ninety days, subject to legal holds, incidents, BAA, DPA, security, and compliance needs.
This policy does not promise zero data retention or any specific AI-provider retention configuration unless that configuration is expressly stated in the applicable agreement, subprocessor terms, or approved customer documentation.
MediAxis may use approved service providers and subprocessors for AI-assisted processing, hosting, document processing, OCR, security, monitoring, support, and related platform operations. Vendor-specific information should be reviewed in the Subprocessor Disclosure.
If a provider changes, suspends, discontinues, materially limits, or no longer makes available a service, model, infrastructure component, security tool, or other dependency used by AI Functionality, LezDo TechMed Pvt Ltd may transition to another provider, modify the affected function, suspend the affected function, or provide a reasonable alternative where commercially practicable.
AI-assisted processing may involve protected health information, special-category health data, confidential legal information, privileged material, claimant information, insured-person information, policy-applicant information, patient information, employment or disability information, financial or billing information, and other sensitive information.
Customers remain responsible for determining whether HIPAA, UK GDPR, EU GDPR, US state privacy law, consumer health law, insurance law, employment law, professional rules, court rules, substance-use treatment confidentiality rules, genetic-information rules, or other laws apply to their Inputs, Outputs, and instructions.
Where HIPAA applies and Customer Data includes protected health information, AI-assisted processing must occur under a completed Business Associate Agreement with the applicable enterprise customer or other authorized contracting party. Customers remain responsible for notices, authorizations, minimum-necessary decisions, disclosure decisions, specially protected record restrictions, and their own covered-entity or business-associate duties.
MediAxis may process personal information from the United States, United Kingdom, European Economic Area, and other regions when customers submit those records or when processing is required to provide the MediAxis Platform. Where UK GDPR, EU GDPR, or similar law requires a transfer mechanism, LezDo TechMed Pvt Ltd will use appropriate contractual, technical, and organizational safeguards as required by applicable law and the applicable Data Processing Agreement or customer agreement.
Customers and users should report suspected AI errors, unsafe outputs, incorrect source references, hallucinations, missing context, privacy concerns, unauthorized AI use, security issues, or output misuse through approved support or security channels. When reporting an issue, users should preserve the source record, affected Output, prompt or instruction context where available, matter identifier, date, user action, and a short description of the concern so the issue can be reviewed and corrected more effectively.
LezDo TechMed Pvt Ltd may investigate, restrict, disable, quarantine, remove, correct, or decline to process Inputs, Outputs, prompts, links, files, or workflows where reasonably necessary to address malware, unlawful content, unauthorized records, security risk, court order, legal obligation, privacy risk, platform protection, third-party rights, or suspected breach of these AI Terms.
Security incident and vulnerability communications must be sent to security@lezdotechmed.com unless a signed agreement provides a different channel. Privacy requests should be sent to privacy@lezdotechmed.com. Formal legal notices must be sent to legal@lezdotechmed.com unless the applicable agreement requires a different notice method.
Physical notices and correspondence may be sent to LezDo TechMed Pvt Ltd, No.210, Level 2, Sonia Plaza, Junction Main Rd, State Bank Colony, Meyyanur, Salem, Tamil Nadu 636004, India.
LezDo TechMed Pvt Ltd may suspend or restrict AI Functionality for a user, account, feature, workflow, file, prompt, or matter where reasonably necessary for security, legal compliance, privacy protection, misuse prevention, provider limitations, account control, or platform integrity.
Customers retain their rights in Customer Data. Subject to the applicable terms, customers may use Outputs for their authorized internal professional workflows. LezDo TechMed Pvt Ltd and its licensors retain rights in MediAxis, software, workflows, templates, prompts, documentation, models, interfaces, product designs, analytics methods, service configuration, platform improvements, and related technology.
Customers are responsible for reviewing, verifying, approving, filing, disclosing, or otherwise using Outputs. Additional ownership treatment may be described in the Terms and Conditions, Customer SaaS Agreement, Customer Data Ownership, AI-Generated Output Ownership / Responsibility, and signed customer agreement where applicable.
LezDo TechMed Pvt Ltd may update these AI Terms for product, legal, security, operational, provider, or compliance reasons. Updated terms will identify the revised effective date. Continued use of AI Functionality after the effective date means the customer and users accept the updated terms, unless a signed agreement provides a different amendment process.
Customer review duties, restrictions on misuse, confidentiality, ownership, data-use restrictions, no-training restrictions, output responsibility, disclaimers, liability-related provisions, and provisions that by their nature should continue will survive expiration or termination.